Sheldon L. Koenig, President and CEO at Esperion Therapeutics, Inc. (ESPR), sold 51,156 shares at $2.72 ($139K) on 2026-03-17, disclosed to the SEC on 2026-03-18.
Seasonal sale ($139k) by President and CEO — this insider has traded ESPR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.72 | 25,578 | $70K | 50.0% |
| 2 | $2.72 | 25,578 | $70K | 50.0% |
| Total | $2.72 avg | 51,156 | $139K | 100% |
| Filing → |
| ESPR | SELL | 2025-09-18 | $159K | — | Filing → |
| ESPR | SELL | 2025-06-18 | $34K | — | Filing → |
| ESPR | SELL | 2025-03-19 | $20K | — | Filing → |